Gene · 1673
Papers4,248
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
841 to 860 of 4,248
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Profiling Blood Serum Extracellular Vesicles in Plaque Psoriasis and Psoriatic Arthritis Patients Reveals Potential Disease Biomarkers. | Int J Mol Sci | 2022 | 35409365 | PubTator, text mining | PubMed |
| The Role of Vitamin D in Supporting Health in the COVID-19 Era. | Int J Mol Sci | 2022 | 35408981 | PubTator, text mining | PubMed |
| Diagnostic and Therapeutic Potential for HNP-1, HBD-1 and HBD-4 in Pregnant Women with COVID-19. | Int J Mol Sci | 2022 | 35408809 | PubTator, text mining | PubMed |
| Potential Immunogenic Activity of Computationally Designed mRNA- and Peptide-Based Prophylactic Vaccines against MERS, SARS-CoV, and SARS-CoV-2: A Reverse Vaccinology Approach. | Molecules | 2022 | 35408772 | PubTator, text mining | PubMed |
| Quinazoline Based HDAC Dual Inhibitors as Potential Anti-Cancer Agents. | Molecules | 2022 | 35408693 | PubTator, text mining | PubMed |
| Next Generation Plasma Proteomics Identifies High-Precision Biomarker Candidates for Ovarian Cancer. | Cancers (Basel) | 2022 | 35406529 | PubTator, text mining | PubMed |
| Microbial Activities and Selection from Surface Ocean to Subseafloor on the Namibian Continental Shelf. | Appl Environ Microbiol | 2022 | 35404072 | PubTator, text mining | PubMed |
| Post-Translational Modifications of BRD4: Therapeutic Targets for Tumor. | Front Oncol | 2022 | 35402244 | PubTator, text mining | PubMed |
| A Comprehensive Review of BET Protein Biochemistry, Physiology, and Pathological Roles. | Front Pharmacol | 2022 | 35401196 | PubTator, text mining | PubMed |
| Deciphering the immunoboosting potential of macro and micronutrients in COVID support therapy. | Environ Sci Pollut Res Int | 2022 | 35391642 | PubTator, text mining | PubMed |
| Junctional epithelium and hemidesmosomes: Tape and rivets for solving the "percutaneous device dilemma" in dental and other permanent implants. | Bioact Mater | 2022 | 35387164 | PubTator, text mining | PubMed |
| Lipocalin 2 Participates in the Epidermal Differentiation and Inflammatory Processes of Psoriasis. | J Inflamm Res | 2022 | 35386225 | PubTator, text mining | PubMed |
| The barrier and beyond: Roles of intestinal mucus and mucin-type O-glycosylation in resistance and tolerance defense strategies guiding host-microbe symbiosis. | Gut Microbes | 2022 | 35380912 | PubTator, text mining | PubMed |
| NUT Carcinoma: Clinicopathologic Features, Molecular Genetics and Epigenetics. | Front Oncol | 2022 | 35372003 | PubTator, text mining | PubMed |
| Role of Interleukin-17A in the Pathomechanisms of Periodontitis and Related Systemic Chronic Inflammatory Diseases. | Front Immunol | 2022 | 35371044 | PubTator, text mining | PubMed |
| Plasma concentrations of cathelicidin and β-defensins and their correlations in patients with basal cell carcinoma. | Postepy Dermatol Alergol | 2022 | 35369619 | PubTator, text mining | PubMed |
| Current Status of Probiotics as Supplements in the Prevention and Treatment of Infectious Diseases. | Front Cell Infect Microbiol | 2022 | 35360101 | PubTator, text mining | PubMed |
| The Interplay Between Cervicovaginal Microbial Dysbiosis and Cervicovaginal Immunity. | Front Immunol | 2022 | 35359942 | PubTator, text mining | PubMed |
| Construction and Characterization of an Intergeneric Fusant That Degrades the Fungicides Chlorothalonil and Carbendazim. | Front Microbiol | 2022 | 35359711 | PubTator, text mining | PubMed |
| NMR Molecular Replacement Provides New Insights into Binding Modes to Bromodomains of BRD4 and TRIM24. | J Med Chem | 2022 | 35357834 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1673/papers?page=43